Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Trimethoprim | C14H18N4O3 | 738-70-5 | Details |
| Rifaximin | C43H51N3O11 | 80621-81-4 | Details |
| HCV-IN-3 | C13H11F2NO | 1401839-25-5 | Details |
| HDAC-IN-4 | C20H21N3O2 | 1252003-13-6 | Details |
| HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| HDACs/mTOR Inhibitor 1 | C28H38N8O5 | 2271413-06-8 | Details |
| H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
| IDH1 Inhibitor 2 | C26H22N4O | 2244895-42-7 | Details |
| IDH1 Inhibitor 3 | C31H25F4N5O3 | 2171081-24-4 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| Haloperidol (D4')；Haloperidol D4' | C21H19ClD4FNO2 | 136765-35-0 | Details |
| Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
| HCV-IN-30 | C36H44N6O4 | 1007882-23-6 | Details |
| HCV-IN-29 | C26H32Cl4N6 | 1009119-83-8 | Details |
| HCV-IN-7 hydrochloride | C40H49ClN8O6S | 1449756-87-9 | Details |
| Helioxanthin 8-1；Helioxanthin analogue 8-1 | C20H12N2O6 | 840529-13-7 | Details |
| HET0016 | C12H18N2O | 339068-25-6 | Details |
| Helvolic acid；Fumigacin | C33H44O8 | 29400-42-8 | Details |
| Helioxanthin derivative 5-4-2；Helioxanthin 5-4-2 | C20H13NO5 | 203935-39-1 | Details |
| H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
| hDHODH-IN-1 | C17H14N2O2 | 1173715-42-8 | Details |
| HIV-1 inhibitor-3 | C9H10F2N2O5 | 1612841-22-1 | Details |
| Histone Acetyltransferase Inhibitor II | C20H16Br2O3 | 932749-62-7 | Details |
| HIF-2α-IN-3 | C12H6ClN5O5 | 313964-19-1 | Details |
| HIF-2α-IN-2 | C17H13F2NO4S | 1672666-82-8 | Details |
| Heptamidine dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
| Mebendazole | C16H13N3O3 | 31431-39-7 | Details |
| Haloperidol D4 | C21H19ClD4FNO2 | 1189986-59-1 | Details |
| HA155；CS-963 | C24H19BFNO5S | 1312201-00-5 | Details |
| HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
| hDHODH-IN-2 | C19H16N2O2 | 183946-00-1 | Details |
| Palonosetron hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| hGPR91 antagonist 1 | C31H23F4N3O | 1314796-00-3 | Details |
| FASN-IN-3 | C24H24N4O | 2097262-60-5 | Details |
| HG-12-6 | C29H27F3N6O2S | 2222354-57-4 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| hDDAH-1-IN-1 TFA | C10H21F3N4O3 | 1229238-70-3 | Details |
| Heptasaccharide Glc4Xyl3 | C39H66O33 | 121591-98-8 | Details |
| Heptamidine；SBi4211 | C21H28N4O2 | 94345-47-8 | Details |
| Cathepsin Inhibitor 2 | C19H21F6N3O | 1017931-53-1 | Details |
| GW311616 hydrochloride；GW311616A | C19H32ClN3O4S | 197890-44-1 | Details |
| GW311616 | C19H31N3O4S | 198062-54-3 | Details |
| H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
| H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
| H-Ser-His-OH | C9H14N4O4 | 67726-09-4 | Details |
| H100 | C18H16N2O6S | 643727-55-3 | Details |
| DPP-IV-IN-2 | C18H26N4O5 | 136259-18-2 | Details |
| HS80 | C19H22N4S | 2138838-57-8 | Details |
| BAY 59-9435；HSL-IN-2 | C14H22N2O3 | 654059-21-9 | Details |
| HSL-IN-1 | C19H13BClF3N2O4 | 2095156-13-9 | Details |
| HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
| HIV-1 integrase inhibitor 4 | C24H20F2N4O5S | 1638504-66-1 | Details |
| HS79 | C19H22N4S | 2138838-56-7 | Details |
| Moxidectin | C37 H53 N O8 | 113507-06-5 | Details |
| HLY78 | C17H17NO2 | 854847-61-3 | Details |
| HKI-357 | C31H29ClFN5O3 | 848133-17-5 | Details |
| HPN-01 | C19H16ClN3O3S | 928655-63-4 | Details |
| Encequidar | C38H36N6O7 | 849675-66-7 | Details |
| Encequidar mesylate | C39H40N6O10S | 849675-87-2 | Details |
| HSL-IN-3 | C14H19BO4 | 346656-34-6 | Details |
| HIV-1 integrase inhibitor 3 | C21H22F2N4O4 | 1638504-56-9 | Details |
| HIV-1 integrase inhibitor | C11H9N3O4 | 544467-07-4 | Details |
| HIV-1 integrase inhibitor 7 | C30H26O16 | 204268-03-1 | Details |
| Hydroxy ziprasidone | C21H21ClN4O2S | 884305-08-2 | Details |
| Hexyl gallate | C13H18O5 | 1087-26-9 | Details |
| Haemanthamine | C17H19NO4 | 466-75-1 | Details |
| Hydroxy desmethyl Bosentan；Ro 64-1056 | C26H27N5O7S | 253688-62-9 | Details |
| HWL-088 | C22H19FO4 | 2378617-96-8 | Details |
| HSV-TK substrate | C11H15N5O4 | 111687-37-7 | Details |
| HSR6071 | C10H12N8O | 111374-21-1 | Details |
| Heme Oxygenase-1-IN-1 hydrochloride；HO-1-IN-1 hydrochloride | C13H16BrClN2 | 1092851-70-1 | Details |
| Heme Oxygenase-1-IN-1；HO-1-IN-1 | C13H15BrN2 | 1093058-52-6 | Details |
| Phenoxybenzamine hydrochloride | C18H22ClNO.ClH | 63-92-3 | Details |
| Hydroxyamine hydrochloride | NH2OH·HCl | 5470-11-1 | Details |
| Hydroxybupropion | C13H18ClNO2 | 92264-81-8 | Details |
| Hydroxycitric acid tripotassium hydrate；Potassium citrate monohydrate | C6H11KO8 | 6100-05-6 | Details |
| (-)-Hydroxycitric acid；Garcinia acid | C6H8O8 | 27750-10-3 | Details |
| Hydroxyzine D4 | C21H27ClN2O2 | 2070014-84-3 | Details |
| Leflunomide | C12H9F3N2O2 | 75706-12-6 | Details |
| Idelalisib D5；CAL-101 D5;GS-1101 D5 | C22H18FN7O | 1830330-31-8 | Details |
| Prothionamide | C9H12N2S | 14222-60-7 | Details |
| Ibrutinib dimer | C50H48N12O4 | 2031255-23-7 | Details |
| Ibrutinib-MPEA | C32H39N9O2 | 1710768-30-1 | Details |
| Ibuprofen-d3；(±)-Ibuprofen D3;Ibuprofen D3 | C13H15D3O2 | 121662-14-4 | Details |
| (-)-Ibuprofenamide；(R)-Ibuprofenamide | C13H17NO3 | 121839-78-9 | Details |
| ICI 118,551 hydrochloride | C17H28ClNO2 | 72795-01-8 | Details |
| ICI 153110 | C11H11N3O | 87164-90-7 | Details |
| IACS-9571；ASIS-P040 | C32H42N4O8S | 1800477-30-8 | Details |
| IAXO-102 | C35H71NO5 | 1115270-63-7 | Details |
| IACS-8803 | C20H23FN10O9P2S2 | 2095690-70-1 | Details |
| IACS-8779 | C21H25N9O10P2S2 | 2243079-26-5 | Details |
| I2906 | C25H37N3O4 | 331963-29-2 | Details |
| Hydroxyzine D8 | C21H19ClD8N2O2 | 1189480-47-4 | Details |
| Ibiglustat (L-Malic acid) | C24H30FN3O7S | 1629063-78-0 | Details |
| Fusidic acid | C31H48O6 | 6990-06-3 | Details |
| Ibrutinib-d5；PCI-32765 D5;Ibrutinib D5 | C25H24N6O2 | 1553977-17-5 | Details |
| IBR2 | C24H20N2O2S | 313526-24-8 | Details |
| I-OMe-Tyrphostin AG 538 | C17H12INO5 | 1094048-77-7 | Details |
| Epanolol；Visacor;ICI141292 | C20H23N3O4 | 86880-51-5 | Details |
| Product Total： Product Page： | ||||
| 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 | ||||